Title:
【発明の名称】レプトスピラ病原体
Document Type and Number:
Japanese Patent JP2002501368
Kind Code:
A
Abstract:
The present invention relates generally to novel isolated species of pathogenic bacteria and to immunoreactive molecules which are derived therefrom and their use in compositions of matter such as vaccine preparations. More particularly, the present invention is directed to a new isolated serovar of Leptospira designated as serovar hurstbridge or serogroup Hurstbridge or L. fainei and diagnostic assays therefor. The present invention further provides vaccines compositions which provide for the passive and active vaccination of animal subjects against Leptospira, in particular serovar hurstbridge or serogroup Hurstbridge or L. fainei.
Inventors:
Chapel, Roderick Jay.
Application Number:
JP53896998A
Publication Date:
January 15, 2002
Filing Date:
March 06, 1998
Export Citation:
Assignee:
Agriculture Victoria Services Proprietary Limited
Pig Research and Development Corporation
Pig Research and Development Corporation
International Classes:
C12N15/09; A61K35/74; A61K39/02; A61P15/00; A61P31/00; A61P43/00; C07K14/20; C07K16/12; C12N1/20; C12N1/21; C12N15/30; C12Q1/68; C12Q1/689; A61K39/00; (IPC1-7): C12N15/09; A61K35/74; A61K39/02; A61P15/00; A61P31/00; A61P43/00; C07K16/12; C12N1/20; C12N1/21; C12Q1/68
Attorney, Agent or Firm:
Takashi Ishida (4 others)